TY - JOUR
T1 - Rapid quantitative pharmacodynamic imaging with Bayesian Estimation
AU - Koller, Jonathan M.
AU - Jonathan Vachon, M.
AU - Larry Bretthorst, G.
AU - Black, Kevin J.
N1 - Publisher Copyright:
© 2016 Koller, Vachon, Bretthorst and Black.
PY - 2016/4/8
Y1 - 2016/4/8
N2 - We recently described rapid quantitative pharmacodynamic imaging, a novel method for estimating sensitivity of a biological system to a drug. We tested its accuracy in simulated biological signals with varying receptor sensitivity and varying levels of random noise, and presented initial proof-of-concept data from functional MRI (fMRI) studies in primate brain. However, the initial simulation testing used a simple iterative approach to estimate pharmacokinetic-pharmacodynamic (PKPD) parameters, an approach that was computationally efficient but returned parameters only from a small, discrete set of values chosen a priori. Here we revisit the simulation testing using a Bayesian method to estimate the PKPD parameters. This improved accuracy compared to our previous method, and noise without intentional signal was never interpreted as signal. We also reanalyze the fMRI proof-of-concept data. The success with the simulated data, and with the limited fMRI data, is a necessary first step toward further testing of rapid quantitative pharmacodynamic imaging.
AB - We recently described rapid quantitative pharmacodynamic imaging, a novel method for estimating sensitivity of a biological system to a drug. We tested its accuracy in simulated biological signals with varying receptor sensitivity and varying levels of random noise, and presented initial proof-of-concept data from functional MRI (fMRI) studies in primate brain. However, the initial simulation testing used a simple iterative approach to estimate pharmacokinetic-pharmacodynamic (PKPD) parameters, an approach that was computationally efficient but returned parameters only from a small, discrete set of values chosen a priori. Here we revisit the simulation testing using a Bayesian method to estimate the PKPD parameters. This improved accuracy compared to our previous method, and noise without intentional signal was never interpreted as signal. We also reanalyze the fMRI proof-of-concept data. The success with the simulated data, and with the limited fMRI data, is a necessary first step toward further testing of rapid quantitative pharmacodynamic imaging.
KW - Bayesian parameter estimation
KW - PK-PD modeling
KW - Pharmacodynamics
KW - Pharmacological imaging
UR - http://www.scopus.com/inward/record.url?scp=84966269469&partnerID=8YFLogxK
U2 - 10.3389/fnins.2016.00144
DO - 10.3389/fnins.2016.00144
M3 - Article
AN - SCOPUS:84966269469
SN - 1662-4548
VL - 10
SP - 1
JO - Frontiers in Neuroscience
JF - Frontiers in Neuroscience
IS - APR
ER -